PreventID® Bladder

PreventID® Bladder is a rapid immunochromatographic test for the simultaneous determination of the bladder cancer marker (BCM, human complement factor H-related protein) and hemoglobin in urine for the early detection of bladder cancer.

Classic rapid tests
Professional medicals
Urine sample

PreventID® Bladder

Only for sale to professional users such as doctors, pharmacists, alternative practitioners and other medically trained personnel.

Early bladder cancer detection

When detected early, bladder cancer has a cure rate of over 90%. Typical signs of disease are blood in urine or pain when urinating. However, in early stages, there may be very small amounts of blood, often not visible. Timely screening with a test that can detect these small amounts is therefore useful and important. After all, in advanced disease with metastasis, a cure is often no longer possible.

Your benefits

  • Increased chances of cure through early detection
  • Smallest (invisible) amounts of blood in the urine are reliably detected
  • Parallel determination of the bladder cancer marker (BCM) and hemoglobin
  • Test results are available after a few minutes

Hint

Only for sale to professional users such as doctors, pharmacists, alternative practitioners and other medically trained personnel.

Sensitivity (compared to cytology)

42.5–97.1 % depending on tumor stage and grade

Specificity

89.5 %

Detection limit

BCM: 500 ng/ml

Hb: 250 ng/ml

Search
Contact
To top